Document is current
Any future updates will be listed below
-
Authors
Romano, Carla
Fehnel, Sheri
Stoddard, Jeffrey
Sadoff, Jerald
Lewis, Sandy
McNulty, Pauline
Chan, Eric K. H.
Evans, Emily
Jamieson, Carol
Slagle, Ashley F.
Mangel, Allen
McQuarrie, Kelly https://orcid.org/0000-0002-2362-1163
-
Funding
Funding for this research was provided by:
Janssen Vaccines and Prevention
- License Information
-
More Information
Article History
Received: 14 December 2021
Accepted: 25 May 2022
First Online: 29 July 2022
Declarations
:
: This study involved human participants but the Institutional Board of the RTI Office of Research Protection exempted this study. According to the materials submitted to the IRB, this study is not under federal oversight. Thus the IRB used 45 CFR 46 as the ethical framework to guide the review. This determination applies only to the activities described in the IRB submission.
: Not applicable.
: C.R., S.F., S.L., E.E., and A.M. are salaried employees of RTI Health Solutions, which received research funding from Janssen during the conduct of this study. J.Sa., J.St., P.M., E.K.H.C., C.J., and K.M. are employed by Janssen Pharmaceuticals, a Johnson & Johnson company and may be Johnson & Johnson stockholders. J.Sa. also reports receiving grants from the Biomedical Advanced Research and Development Authority (BARDA). A.F.S. reports personal fees for consulting services from Janssen Pharmaceuticals.
